Chemistry Reference
In-Depth Information
[33] P.C.D. Hawkins, A.G. Skillman and A. Nicholls, Comparison of shape-matching and docking
as virtual screening tools,
J. Med. Chem
., 50, 74-82 (2007).
[34] X.Q. Lewell, D.B. Judd, S.P. Watson and M.M. Hann, RECAP - retrosynthetic combinatorial
analysis procedure: a powerful new technique for identifying privileged molecular fragments
with useful applications in combinatorial chemistry,
J. Chem. Inf. Comput. Sci.
,
38
, 511-522
(1998).
[35] A.A. Shelat and R.K. Guy, Scaffold composition and biological relevance of screening libraries,
Nat. Chem. Biol
.,
3
, 442-446 (2007).
[36] P.J. Hajduk, M. Bures, J. Praestgaard and S.W. Fesik, Privileged molecules for protein binding
identified from NMR-based screening,
J. Med. Chem
.,
34
, 3443-3447 (2000).
[37] M.S. Congreve MS, D.J. Davis, L. Devine, C. Granata, M. O'Reilly, P.G. Wyatt and H. Jhoti,
Detection of ligands from a dynamic combinatorial library by X-ray crystallography.
Angew
Chem Int Ed
.,
42
, 4479-4482 (2003).
[38] C.A. Lepre, Library design for NMR-based screening,
Drug Discov. Today
,
6
, 133-140 (2001).
[39] A. Schuffenhauer, S. Ruedisser, A.L. Marzinzik, W. Jahnke, M. Blommers, P. Selzer and
E. Jacoby, Library design for fragment based screening,
Curr. Top. Med. Chem.
,
5
, 751-761
(2005).
[40] D.J. Maly, I.C. Choong and J.A. Ellman, Combinatorial target-guided ligand assembly:
Identification of potent subtype-selective c-Src inhibitors,
Proc. Natl. Acad. Sci. USA
,
7
,
2419-2424 (2000).
[41] M. Whiting, J. Muldoon, Y.C. Lin, S.M. Silverman, W. Lindstrom, A.J. Olson, H.C. Kolb,
M.G. Finn, K.B. Sharpless, J.H. Elder and V.V. Fokin, Inhibitors of HIV-1 protease by using
in
situ
click chemistry,
Angew. Chem. Int. Ed.
,
45
, 1435-1439 (2006).
[42] S.B. Shuker, P.J. Hajduk, R.P. Meadows and S.W. Fesik, Discovering high-affinity ligands for
proteins: SAR by NMR,
Science
,
274
,1531-1534 (1996).
[43] G.L. Card, L. Blasdel, B.P. England, C. Zhang, Y. Suzuki, S. Gillette, D. Fong, P.N. Ibrahim,
D.R. Artis, G. Bollag, M.V. Milburn, S.H. Kim, J. Schlessinger and K.Y. Zhang, A family of
phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design,
Nat. Biotechnol
.,
23
, 201-207 (2005).
[44] G.W. Bemis and M.A. Murcko, The properties of known drugs. 1. Molecular frameworks,
J. Med. Chem
.,
39
, 2887-2893 (1996).
[45] G.W. Bemis and M.A. Murcko, The properties of known drugs. 2. Side chains,
J. Med. Chem
.,
42
, 5095-5099 (1999).
[46] G.M. Rishton, Reactive compounds and
in vitro
false positives in HTS,
Drug. Discov. Today
,
2
, 382-384 (1997).
[47] M. Joshi, C. Vargas, P. Boisguerin, A. Diehl, G. Krause,P.Schmieder, K. Moelling, V. Hagen,
M. Schade and H. Oschkinat, Discovery of low-molecular-weight ligands for the AF6 PDZ
domain,
Angew. Chem. Int. Ed
.,
45
, 3790-95 (2006).
[48] K. Babaoglu and B.K. Shoichet, Deconstructing fragment-based inhibitor discovery,
Nat.
Chem. Biol
.,
2
, 720-723 (2006).
[49] M. Manger, M. Scheck, H. Prinz, J.P. von Kries, T. Langer, K. Saxena, H. Schwalbe,A. Furstner,
J. Rademann and H. Waldmann, Discovery of
Mycobacterium tuberculosis
protein tyrosine
phosphatase A (MptpA) inhibitors based on natural products and a fragment-based approach,
ChemBioChem
,
6
, 1749-1753 (2005).
[50] S.V. Trepalin, V.A. Gerasimenko, A.V. Kozyukov, N.P. Savchuk and A.A. Ivaschenko, New
diversity calculation algorithms used for compound selection.,
J. Chem. Inf. Comput. Sci
.,
42
,
249-258 (2002).
[51] N. Benson, H.F. Boyd, J.R. Everett, J. Fries, P. Gribbon, N. Haque, K. Henco, T. Jessen,
W.H. Martin, T.J. Mathewson, R.E. Sharp, R.W. Spencer, F. Stuhmeier, M.S. Wallace and
